Biopharmaceutical company Aimmune Therapeutics says the US Food and Drug Administration has approved its drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17 and that it had priced it at $US890 ($A1,330) per month. Via news.com.au — Australia’s #1 news site https://www.news.com.au
The Greco family’s rural retreat was too far from the beach for their liking - so they built one in their backyard, and now its causing a frenzy across the state. Via news.com.au — Australia’s leading news site https://www.news.com.au
Comments
Post a Comment